| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/03/2005 | US6887493 Core with moisture sensitive overcoatings; storage stability |
| 05/03/2005 | US6887492 Magnesium plus interactive agent delivery |
| 05/03/2005 | US6887487 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | US6887459 Administering inhalant with particulate carrier or diluent for treatment of chronic obstructive pulmonary disease |
| 05/03/2005 | US6887458 Bead comprising mixture of polyvinyl alcohol and platinum (and titania) isotoped by neutron radiation; anticarcinogenic and antitumor agents |
| 05/03/2005 | US6887307 Pullulan film compositions |
| 05/03/2005 | US6887269 Ophthalmologic implant |
| 05/03/2005 | US6886568 Method for fabricating cell-containing implants |
| 05/03/2005 | CA2486473A1 Vaginal care composition |
| 05/03/2005 | CA2437412C Delayed release microtablet of b-phenylpropiophenone derivatives |
| 05/03/2005 | CA2390636C Stabilized formulations comprising amlodipine maleate |
| 05/03/2005 | CA2355657C Biodegradable ph/thermosensitive hydrogels for sustained delivery of biologically active agents |
| 05/03/2005 | CA2325045C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 05/03/2005 | CA2202531C Lyophilizate of lipid complex of water insoluble camptothecins |
| 05/03/2005 | CA2156708C Transmucosal delivery of macromolecular drugs |
| 05/03/2005 | CA2096001C Compositions of gastric acid-resistant microspheres containing salts of bile acid |
| 05/03/2005 | CA2091152C Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |
| 04/30/2005 | CA2447566A1 Geletins with improved gliding power, to processes for their preparation and their applications |
| 04/28/2005 | WO2005051363A1 Coated conditioners for use in foods and pharmaceuticals |
| 04/28/2005 | WO2005038430A2 Viral fibers |
| 04/28/2005 | WO2005037973A1 Aqueous compositions comprising vesicles having certain vesicle permeability |
| 04/28/2005 | WO2005037949A2 Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine |
| 04/28/2005 | WO2005037946A1 Adhesive patch for external use on skin |
| 04/28/2005 | WO2005037911A2 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 04/28/2005 | WO2005037895A1 Pectin films prepared from gamma irradiated pectin |
| 04/28/2005 | WO2005037784A2 Crystalline form of gamma-aminobutyric acid analog |
| 04/28/2005 | WO2005037346A2 Method for providing long-lasting pain relief through intrathecal administration of civamide |
| 04/28/2005 | WO2005037341A2 Small particle aerosol liposomes for delivery of anti-cancer drugs |
| 04/28/2005 | WO2005037336A1 Hydrogel-containing medical articles and methods of using and making the same |
| 04/28/2005 | WO2005037325A1 X-ray contrast medium containing liposome and method for preparation thereof |
| 04/28/2005 | WO2005037319A1 Composition for tablet rapidly disintegrable in mouth |
| 04/28/2005 | WO2005037296A1 Anti-coronavirus agent |
| 04/28/2005 | WO2005037268A1 Composition containing retinoic acid nanoparticles coated with polyvalent metal inorganic salt |
| 04/28/2005 | WO2005037267A1 Method of controlling paticle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method |
| 04/28/2005 | WO2005037264A1 Jelly preparation containing biguanide medicine |
| 04/28/2005 | WO2005037262A1 Citicoline-based composition in combination with vitamins for the prevention and treatment of eye pathologies |
| 04/28/2005 | WO2005037256A2 Liquid preparation containing tobramycin |
| 04/28/2005 | WO2005037255A1 Tablet with aqueous based-sustained release coating |
| 04/28/2005 | WO2005037254A1 Tablet quickly disintegrating in oral cavity |
| 04/28/2005 | WO2005037253A1 Process for preparing a co-precipitate of a non-crystalline solid drug substance |
| 04/28/2005 | WO2005037252A1 Sterile gelling agents |
| 04/28/2005 | WO2005037251A1 Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds |
| 04/28/2005 | WO2005037249A1 Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 04/28/2005 | WO2005037248A1 Glycoprotein and/or glycomacropeptide containing preparations for medical uses |
| 04/28/2005 | WO2005037247A2 Oral matrix formulations of doxazosin |
| 04/28/2005 | WO2005037246A2 Aqueous aerosol preparation |
| 04/28/2005 | WO2005037245A2 A multiple route medication for the treatment of rhinitis and asthma |
| 04/28/2005 | WO2005037238A2 Chewing gum for the remineralisation of tooth enamel |
| 04/28/2005 | WO2005037203A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 04/28/2005 | WO2005037192A2 Ibuprofen narcotic composition and method for making same |
| 04/28/2005 | WO2005037188A2 Therapeutic agent for periodontal disease |
| 04/28/2005 | WO2005037158A1 Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide |
| 04/28/2005 | WO2005037157A1 Enhancing transdermal administration of hydrophilic drugs |
| 04/28/2005 | WO2005025553A3 Treatment of disorders of nervous systemsystem with fty720 |
| 04/28/2005 | WO2005018533A3 Eletrostatically charged nasal application product with increased strength |
| 04/28/2005 | WO2005016284A3 Gloves containing dry powdered aloe and method of manufacturing |
| 04/28/2005 | WO2005011813A3 Treatment of ocular disease |
| 04/28/2005 | WO2005009738A3 Application of a bioactive agent to a delivery substrate |
| 04/28/2005 | WO2005007137A3 Tablets containing ambroxol |
| 04/28/2005 | WO2005007115A3 Pharmaceutical composition for inhibiting acid secretion |
| 04/28/2005 | WO2005003292A3 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 04/28/2005 | WO2005001023A3 Method and carrier complexes for delivering molecules to cells |
| 04/28/2005 | WO2004103342A3 Injectable sustained release compositions |
| 04/28/2005 | WO2004093848A3 Dry power inhaler devices and dry power formulations for enhancing dosing efficiency |
| 04/28/2005 | WO2004093643A3 Magnetically controllable drug and gene delivery stents |
| 04/28/2005 | WO2004075826A3 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
| 04/28/2005 | WO2004075822A8 Pharmaceutical composition for transdermal or transmucosal administration |
| 04/28/2005 | WO2004070557A3 Method and system for medical device connectivity |
| 04/28/2005 | WO2004060396A3 Immunogenic compositions containing phospholpid |
| 04/28/2005 | WO2004060378A8 Compositions comprising particles containing alumina with compounds bound to the alumina surface, delivery systems and methods of preparation thereof |
| 04/28/2005 | WO2004058217A3 Water-soluble film for oral use |
| 04/28/2005 | WO2004050034A3 Prolonged suppression of electrical activity in excitable tissues |
| 04/28/2005 | WO2004049907A3 Compositions and methods for treating transplants |
| 04/28/2005 | WO2004032963A9 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/28/2005 | WO2004028337A3 Implantable sensor method and system |
| 04/28/2005 | WO2003101425A8 Therapeutic agent-containing polymeric nanoarticles |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003087389A3 Biologic modulations with nanoparticles |
| 04/28/2005 | US20050090891 Stent lining |
| 04/28/2005 | US20050090808 Multi-processor medical device |
| 04/28/2005 | US20050090800 Method for transdermal delivery of permeant substances |
| 04/28/2005 | US20050090798 Aerosolized active agent delivery |
| 04/28/2005 | US20050090564 Compositions and treatments of bacterial vaginosis |
| 04/28/2005 | US20050090557 Methods and compositions for administration of TRPV1 agonists |
| 04/28/2005 | US20050090556 Method for treatment of external secretion disorders |
| 04/28/2005 | US20050090554 Administering baclofen, or a salt thereof, to relieve at least one symptom of gastroparesis other than vomiting |
| 04/28/2005 | US20050090547 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 04/28/2005 | US20050090542 crystalline polymorphic dosage forms of anticholesterol agents; statins |
| 04/28/2005 | US20050090530 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2, 4-dione and pharmaceutical compositions comprising the same |
| 04/28/2005 | US20050090520 Treatment of disease or injury of the nervous system with FTY720 |
| 04/28/2005 | US20050090481 having improved stability and side effect reduction; tissue-targeted therapy |
| 04/28/2005 | US20050090478 Platinum complexes and their use in cancer treatment |
| 04/28/2005 | US20050090473 Formulations and methods of treating inflammatory bowel disease |
| 04/28/2005 | US20050090459 Crystal forms of azithromycin |
| 04/28/2005 | US20050090451 Treatment of cancer with glutamine |
| 04/28/2005 | US20050090444 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090427 Delivery of drugs to the bloodstream in toothpaste |
| 04/28/2005 | US20050089960 Biosynthesis; immunoglobulin signal peptides; fusion proteins; for delivery to the central nervous system and eye by gene therapy; host cells |